10:04 AM EST - Microbix Biosystems Inc : Reports results for its third quarter of fiscal 2019, the three-month period ending June 30, 2019. Sales of $3.1 million for Q3 were down slightly vs. Q3 2018 and were to antigen customers spread across all geographic regions. Total Q3 revenues were $3,110,615, a 4% decrease from Q3 2018 revenues of $3,235,224. Net loss was $191,322, compared with a net gain of $958 in the prior-year quarter. Microbix Biosystems Inc
shares T.MBX are trading down $0.01 at $0.25.
